中国远大集团有限责任公司简介(英文版)

中国远大集团有限责任公司简介

Company Profile of China Grand Enterprises, Inc.

China Grand Enterprises, Inc. (hereinafter referred to as CGE), established in 1993, is a joint-stock group company, headquartered in Grand Place, Beijing Asian Games Village. As an investment company engaged in operation and management, CGE’s core businesses cover pharmaceuticals and healthcare, property investment, commercial trade business, financial services and other industries.

1. Pharmaceuticals and Healthcare Industry

In the field of pharmaceuticals and healthcare industry, CGE has established several core industrial platforms within her controlled subsidiary companies. These include Huadong Pharmaceutical Co. Ltd. that plays a leading role in fermentation-based pharmaceutical production, Grand Pharma (China) Co. Ltd. a leader in synthetic chemistry-based pharmaceutical production, Lei Yunshang Pharmaceutical Group with a nearly 300-year history operating in the production of modern Traditional Chinese Medicine, and Grand Shuyang Pharmaceutical Co., Ltd. focusing on the production of blood products, vaccines and other biopharmaceutical products. CGE pharmaceutical and healthcare industry produces nearly a thousand pharmaceutical products which belong to three major categories including synthetic chemical drugs, traditional Chinese medicines and biopharmaceuticals consisting mainly of blood products and vaccines. Among the products of CGE pharmaceutical and healthcare industry are included various bulk active pharmaceutical ingredients (APIs), steroid hormones, adrenalines and a variety of other specialty APIs, fine chemicals and chemical intermediates, healthcare products and various other classes of pharmaceutical related products. CGE pharmaceutical and healthcare industry has established marketing systems in various specific fields, and many products have passed European COS certifications and US FDA inspections.

CGE views her pharmaceutical R&D as having strategic importance and continues to invest a

large amount of funds in specific areas. Multiple approaches through the build-up of internal R&D capacity, establishing alliances with academic institutions and international collaborations have resulted in the successful development and launch of many new products in recent years. CGE has built a comprehensive business model in her pharmaceuticals and healthcare industry that integrates R&D, production and marketing and distribution into one with a combination of traditional Chinese and Western medicines, and domestic and global market focuses.

2. Property Investment

China Grand Property Investment Group (hereinafter referred to as CGPIG), an affiliate of CGE, is a holding group company that develops commercial real estate and residential real estate. Its businesses include the investment and development of shopping malls, hotels, office buildings and high-, middle- and low-end residences. Its investment regions cover Beijing, Tianjin, Zhejiang, Guangdong, Sichuan, Guizhou, Shaanxi, Hainan, Heilongjiang, Jilin and other provinces and cities. CGPIG has been consistently increasing land reserves, attracting high-level talents, and strengthening market operational capacity, and has built a solid foundation for sustainable development.

3. Financial Services Industry

The financial services industry is one of the important areas of CGE investment and development. In recent years, CGE has established securities companies, commercial banks and other financial institutions. CGE will continue to increase investment in the area of financial services for further growth.

4. Commercial Trade Business

Grand Resources Group Co. Ltd. (hereinafter referred to as GRG), established in 1994, is among the largest trading companies for commercial goods in China. For the past five years, it has been c onsecutively listed in the “Top 500 Enterprises of China”, and in the “Top 100 Service